| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.267 | 12.343 | 16.191 | 16.688 | 17.543 | 15.761 | 17.301 | 21.450 | 24.328 | 19.596 |
| Total Income - EUR | 10.518 | 12.343 | 16.191 | 16.688 | 17.543 | 15.929 | 17.303 | 21.450 | 24.328 | 19.616 |
| Total Expenses - EUR | 9.474 | 7.905 | 11.919 | 13.891 | 15.197 | 11.831 | 12.235 | 11.940 | 13.548 | 11.310 |
| Gross Profit/Loss - EUR | 1.044 | 4.438 | 4.272 | 2.797 | 2.346 | 4.097 | 5.068 | 9.511 | 10.781 | 8.306 |
| Net Profit/Loss - EUR | 728 | 4.068 | 3.786 | 2.630 | 1.991 | 3.654 | 4.549 | 8.867 | 8.991 | 6.684 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Lumiviva Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 835 | 733 | 720 | 707 | 693 | 593 | 506 | 494 | 492 | 1.112 |
| Current Assets | 2.142 | 3.401 | 2.977 | 2.440 | 3.153 | 5.842 | 5.456 | 5.302 | 4.671 | 1.742 |
| Inventories | 1.046 | 1.067 | 1.333 | 1.309 | 1.663 | 1.259 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.476 | 1.264 | 1.117 | 1.001 | 1.217 | 1.306 | 1.213 | 1.624 | 1.575 |
| Cash | 1.096 | 858 | 380 | 14 | 490 | 3.366 | 4.150 | 4.089 | 3.047 | 167 |
| Shareholders Funds | 4.203 | 4.121 | 3.839 | 2.682 | 2.042 | 3.703 | 4.597 | 8.916 | 9.039 | 6.732 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.503 | 3.737 | 3.520 | 4.139 | 5.449 | 6.308 | 5.734 | 1.636 | 865 | 836 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Lumiviva Med Srl